Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
CHRS - TOTAL RECEIVABLES
Total Receivables CHRS - Coherus BioSciences, Inc.
261 M
LAST VALUE
45.52%
2 YEAR CAGR
0.00%
5 YEAR CAGR
91.88%
10 YEAR CAGR